Crohn disease Trials in Beersheba, Israel
Conditions / Crohn disease / Beersheba, Israel
Clinical trials for Crohn disease investigate a range of treatment strategies and patient populations.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05668013 | A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT02403323 | Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144 | TERMINATED | PHASE3 |
| NCT02394028 | A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease | COMPLETED | PHASE3 |
| NCT06221254 | A Smartphone Application for Added Psychological Wellbeing in Crohn's Disease | RECRUITING | — |
| NCT05499130 | A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease | COMPLETED | PHASE2 |
| NCT00552344 | A Study to Evaluate Safety of Long Term Therapy of Certolizumab Pegol Patients With Crohn's Disease | COMPLETED | PHASE3 |
| NCT02596893 | Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease | TERMINATED | PHASE3 |
| NCT05197049 | A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT03841045 | Unraveling a Potential Connection Between Bilirubin Metabolism, Gut Microbiota and Inflammatory Bowel Diseases | UNKNOWN | — |
| NCT00552058 | Study to Evaluate Efficacy and Safety of Certolizumab Pegol for Induction of Remission in Patients With Crohn's Disease | COMPLETED | PHASE3 |